How Does HIV Cause AIDS?
The DOI matches its Crossref record; 129 of the 130 references it cites were found in a registry or an index.
Abstract
Many questions have been posed about acquired immunodeficiency syndrome (AIDS) pathogenesis. Is human immunodeficiency virus (HIV) both necessary and sufficient to cause AIDS? Is AIDS essentially an autoimmune disease, triggering apoptosis, or is virus infection the cause of T helper lymphocyte depletion? What is the significance of HIV tropism and the role of macrophages and dendritic cells in AIDS? Is there viral latency and why is there usually a long period between infection and AIDS? Is HIV variation a crucial aspect of its pathogenesis and, if so, do virulent strains emerge? Although this article provides few definitive answers, it aims to focus commentary on salient points. Overall, it is increasingly evident that both the tropism and burden of HIV infection correlate closely with the manifestations of disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Barré-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., et al. (1983) · Science · doi:10.1126/science.6189183 · Cited by 7,038
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
Dalgleish, A. G., Beverley, P. C. L., Clapham, P. R., Crawford, D. H., Greaves, M. F., & Weiss, R. A. (1984) · Nature · doi:10.1038/312763a0 · Cited by 3,533
Self-citationGottlieb, M. S., Schroff, R., Schanker, H. M., Weisman, J. D., Fan, P. T., Wolf, R. A., & Saxon, A. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112103052401 · Cited by 2,728
T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV
Klatzmann, D., Champagne, E., Chamaret, S., Gruest, J., Guetard, D., Hercend, T., Gluckman, J.-C., & Montagnier, L. (1984) · Nature · doi:10.1038/312767a0 · Cited by 2,436
Jonjić, S., Mutter, W., Weiland, F., Reddehase, M. J., & Koszinowski, U. H. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.4.1199 · Cited by 2,105
Pantaleo, G., Graziosi, C., Demarest, J. F., Butini, L., Montroni, M., Fox, C. H., Orenstein, J. M., Kotler, D. P., & Fauci, A. S. (1993) · Nature · doi:10.1038/362355a0 · Cited by 1,808
The Role of Mononuclear Phagocytes in HTLV-III/LAV Infection
Gartner, S., Markovits, P., Markovitz, D. M., Kaplan, M. H., Gallo, R. C., & Popovic, M. (1986) · Science · doi:10.1126/science.3014648 · Cited by 1,807
Embretson, J., Zupancic, M., Ribas, J. L., Burke, A., Racz, P., Tenner-Racz, K., & Haase, A. T. (1993) · Nature · doi:10.1038/362359a0 · Cited by 1,419
A TH1→TH2 switch is a critical step in the etiology of HIV infection
Clerici, M., & Shearer, G. M. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90208-3 · Cited by 1,390
High Levels of HIV-1 in Plasma During All Stages of Infection Determined By Competitive PCR
Piatak, M., Saag, M. S., Yang, L. C., Clark, S. J., Kappes, J. C., Luk, K.-C., Hahn, B. H., Shaw, G. M., & Lifson, J. D. (1993) · Science · doi:10.1126/science.8096089 · Cited by 1,237
Research works printed but not linked: 13
- ARMSTRONG, J. A., IMMUNOLOGY TODAY 6: 121 (1985).
- ASJO, B, LANCET 2: 234 (1986).
- COLLIN M THESIS U OXFORD (1992).
- GOUGEON, M. L., COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE III-SCIENCES DE LA VIE-LIFE SCIENCES 312: 529 (1991).
- HO, D. D., NEW ENGLAND JOURNAL OF MEDICINE 321: 1621 (1989). · DOI · Paper page
- HUMPHREY, J.H., VIRUS-LIKE PARTICLES IN AIDS-RELATED LYMPHADENOPATHY, LANCET 2: 643 (1984).
- MACETONIA, S.E., IMMUNOLOGY 75: 576 (1992).
- MIEDEMA, F, IMMUNODEFIC REV 3: 173 (1992).
- Mulder D. abstract PoC 4021 VIII International AIDS Conference (1992).
- Oka S. abstract PoC 4752 VIII International AIDS Conference (1992).
- SHEPPARD, H. W., JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY 5: 143 (1992).
- VALENTIN A THESIS KAROLINSKA I (1992).
- Weiss, R. A., The Retroviridae 2: 1 (1993).
Cited by
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M., & Markowitz, M. (1995) · Nature · doi:10.1038/373123a0 · Cited by 4,267
Homing and cellular traffic in lymph nodes
von Andrian, U. H., & Mempel, T. R. (2003) · Nature Reviews Immunology · doi:10.1038/nri1222 · Cited by 1,281
Waldrop, S. L., Pitcher, C. J., Peterson, D. M., Maino, V. C., & Picker, L. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119338 · Cited by 545
Nano and microparticles as controlled drug delivery devices.
Kumar, M. N. R. (2000) · PubMed · Cited by 797
Transmission of disease through transplantation of musculoskeletal allografts.
Tomford, W. W. (1995) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-199511000-00017 · Cited by 474
Biomedical applications of boronic acid polymers
Cambre, J. N., & Sumerlin, B. S. (2011) · Polymer · doi:10.1016/j.polymer.2011.07.057 · Cited by 435
Cytokine Signals Are Sufficient for HIV-1 Infection of Resting Human T Lymphocytes
Unutmaz, D., KewalRamani, V. N., Marmon, S., & Littman, D. R. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.11.1735 · Cited by 427
A SERS-based lateral flow assay biosensor for highly sensitive detection of HIV-1 DNA
Fu, X., Cheng, Z., Yu, J., Choo, P., Chen, L., & Choo, J. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2015.11.099 · Cited by 377
“This HIV-1 virus sometimes causes acquired immunodeficiency syndrome (AIDS), which produces disorders and infections and usually leads to death (Douek et al., 2009; Weiss, 1993).”
BackgroundRe, F., Braaten, D., Franke, E. K., & Luban, J. (1995) · Journal of Virology · doi:10.1128/jvi.69.11.6859-6864.1995 · Cited by 375
Ginseng, the 'Immunity Boost': The Effects of Panax ginseng on Immune System
Kang, S.-W., & Min, H.-Y. (2012) · Journal of Ginseng Research · doi:10.5142/jgr.2012.36.4.354 · Cited by 349
Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen
Bendinelli, M., Pistello, M., Lombardi, S., Poli, A., Garzelli, C., Matteucci, D., Ceccherini-Nelli, L., Malvaldi, G., & Tozzini, F. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.1.87 · Cited by 330
Apoptosis: definition, mechanisms, and relevance to disease
Saikumar, P., Dong, Z., Mikhailov, V., Denton, M., Weinberg, J. M., & Venkatachalam, M. A. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00259-4 · Cited by 327
Cannabinoids: Therapeutic Use in Clinical Practice
Pagano, C., Navarra, G., Coppola, L., Avilia, G., Bifulco, M., & Laezza, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063344 · Cited by 240
“Acquired Immunodeficiency Syndrome (AIDS) is the end-stage disease of human immunodeficiency virus (HIV) infection [115].”
BackgroundBCL2 Family of Apoptosis-Related Genes: Functions and Clinical Implications in Cancer
Thomadaki, H., & Scorilas, A. (2006) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360500295626 · Cited by 245
Construction of a Novel Virus That Targets HIV-1-Infected Cells and Controls HIV-1 Infection
Schnell, M. J., Johnson, J. E., Buonocore, L., & Rose, J. K. (1997) · Cell · doi:10.1016/s0092-8674(00)80350-5 · Cited by 227
“Weiss, R.A., and Axel, R. (1986). The T4 gene encodes the AIDS”
Moore, J. P., Cao, Y., Ho, D. D., & Koup, R. A. (1994) · Journal of Virology · doi:10.1128/jvi.68.8.5142-5155.1994 · Cited by 218
Su, L., Kaneshima, H., Bonyhadi, M., Salimi, S., Kraft, D., Rabin, L., & McCune, J. M. (1995) · Immunity · doi:10.1016/1074-7613(95)90076-4 · Cited by 215
Xiao, S., Tian, Z., Wang, Y., Si, L., Zhang, L., & Zhou, D. (2018) · Medicinal Research Reviews · doi:10.1002/med.21484 · Cited by 213
HIV-Specific T-Helper Activity in Seronegative Health Care Workers Exposed to Contaminated Blood
Clerici, M. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510250058035 · Cited by 207
Dutta, T., & Jain, N. K. (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.12.007 · Cited by 200
Ankersmit, H. J., Tugudea, S., Spanier, T., Weinberg, A. D., Artrip, J. H., Burke, E. M., Flannery, M., Mancini, D., Rose, E. A., Edwards, N. M., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10359-8 · Cited by 194
Journal of Pharmaceutical and Biomedical Sciences
(2016) · Journal of Pharmaceutical and Biomedical Sciences · doi:10.20936/jpbms · Cited by 195
Huang, Y., Zhang, L., & Ho, D. D. (1995) · Journal of Virology · doi:10.1128/jvi.69.1.93-100.1995 · Cited by 190
Gardasil-9: A global survey of projected efficacy
Zhai, L., & Tumban, E. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.03.016 · Cited by 165
Sharma, P., & Garg, S. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.019 · Cited by 165
Paudel, V., & Baral, K. P. (2015) · Reproductive Health · doi:10.1186/s12978-015-0032-9 · Cited by 173
Dutta, T., Agashe, H. B., Garg, M., Balasubramanium, P., Kabra, M., & Jain, N. K. (2007) · Journal of drug targeting · doi:10.1080/10611860600965914 · Cited by 157
“In tissues like lung and the brain, HIV is located primarily in macrophage (Mac) like cells (i.e. alveolar Mac and microglia, respectively) (Levy 1993; Weiss 1993).”
BackgroundNon-polymeric nano-carriers in HIV/AIDS drug delivery and targeting
Gupta, U. D., & Jain, N. K. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.018 · Cited by 162
Bender, A. R., von Briesen, H., Kreuter, J., Duncan, I. B. R., & Rübsamen‐Waigmann, H. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.6.1467 · Cited by 177
Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery
Jain, S., Gupta, Y., Jain, A., Saxena, A. R., Khare, P., & Jain, A. (2008) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2007.11.004 · Cited by 143
Exploring the use of novel drug delivery systems for antiretroviral drugs
Ojewole, E. B., Mackraj, I., Naidoo, P., & Govender, T. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.06.020 · Cited by 140
HIPdb: A Database of Experimentally Validated HIV Inhibiting Peptides
Qureshi, A., Thakur, N., & Kumar, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054908 · Cited by 133
Lymphatic targeting of zidovudine using surface-engineered liposomes
Kaur, C. D., Nahar, M., & Jain, N. K. (2008) · Journal of drug targeting · doi:10.1080/10611860802475688 · Cited by 127
“The human immunodeficiency viruses (HIV) generally encompasses two broad categories HIV-1, the predominant AIDS causing virus in the world, and HIV-2, a biologically distinct second type of AIDS virus, identified in 1986 and generally restricted in West Africa (Weiss 1993).”
BackgroundPaul, B. K., Ray, D., & Guchhait, N. (2012) · Physical Chemistry Chemical Physics · doi:10.1039/c2cp42539d · Cited by 119
Enhanced transdermal delivery of an anti-HIV agent via ethanolic liposomes
Dubey, V., Mishra, D. K., Nahar, M., Jain, V. K., & Jain, N. K. (2010) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2010.01.002 · Cited by 118
Ye, Y., & Kou, C. (2012) · Mathematics and Computers in Simulation · doi:10.1016/j.matcom.2012.01.004 · Cited by 116
Lectins with Anti-HIV Activity: A Review
Akkouh, O., Ng, T. B., Singh, S., Yin, C., Dan, X., Chan, Y. S., Pan, W., & Cheung, R. C. F. (2015) · Molecules · doi:10.3390/molecules20010648 · Cited by 117
“In humans the condition is manifested by progressive failure of the immune system [5, 9] .”
BackgroundSolid-State NMR Studies of HIV-1 Capsid Protein Assemblies
Han, Y. H., Ahn, J., Concel, J., Byeon, I. L., Gronenborn, A. M., Yang, J., & Polenova, T. E. (2010) · Journal of the American Chemical Society · doi:10.1021/ja908687k · Cited by 124
Garnett, G. P., & Anderson, R. M. (1994) · Mathematical Medicine and Biology A Journal of the IMA · doi:10.1093/imammb/11.3.161 · Cited by 111
Kirchhoff, F., Easterbrook, P., Douglas, N. W., Troop, M., Greenough, T. C., Weber, J. N., Carl, S., Sullivan, J. L., & Daniels, R. S. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.5497-5508.1999 · Cited by 111
Gold Nanoparticles as an HIV Entry Inhibitor
Vijayakumar, S., & Ganesan, S. (2012) · Current HIV Research · doi:10.2174/157016212803901383 · Cited by 105
“[1] Weiss RA.”
BackgroundTricyclic ureas: A new class of HIV-1 protease inhibitors
Han, W., Pelletier, J. C., & Hodge, C. N. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00659-3 · Cited by 105
Broadly neutralizing antibodies for HIV-1: efficacies, challenges and opportunities
Liu, Y., Cao, W., Sun, M., & Li, T. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1713707 · Cited by 123
Frey, S., Marsh, M., Günther, S., Pelchen–Matthews, A., Stephens, P. E., ORTLEPP, S., & Stegmann, T. (1995) · Journal of Virology · doi:10.1128/jvi.69.3.1462-1472.1995 · Cited by 103
“However, the cell surface expression of gp120 is slow and inefficient ( 3 , 16, 58), and therefore, knowing that the fusion activity of CHO-gp160 cells at 378C was not delayed after incubation of the cells for several hours at 258C (Fig. 2), we think that the expression of gp120 at 258C was not changed”
BackgroundDissent in science: Styles of scientific practice and the controversy over the cause of AIDS
Fujimura, J. H., & Chou, D. Y. (1994) · Social Science & Medicine · doi:10.1016/0277-9536(94)90219-4 · Cited by 96
Zhou, J., Gan, N., Li, T., Hu, F., Li, X., Wang, L., & Zheng, L. (2013) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2013.10.044 · Cited by 91
“Acquired immune deficiency syndrome (AIDS) is caused by infection with human immunodeficiency virus (HIV), and is the end-stage of disease (Weiss, 1993).”
BackgroundHuang, L., Joshi, A., Willey, R. L., Orenstein, J. M., & Jeang, K.-T. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06583.x · Cited by 93
Recent Advances and Future Perspectives of Triazole Analogs as Promising Antiviral Agents
Kharb, R., Yar, M. S., & Sharma, P. C. (2010) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955711793564051 · Cited by 89
“Antiretroviral drugs are medications for the treatment of infections by retroviruses, primarily HIV which causes AIDS [15, 16].”
BackgroundBrady, H. J. M., Pennington, D. J., Miles, C. G., & Dzierzak, E. A. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06186.x · Cited by 89
Alzheimer’s disease as a viral disease: Revisiting the infectious hypothesis
Bruno, F., Abondio, P., Bruno, R., Ceraudo, L., Paparazzo, E., Citrigno, L., Luiselli, D., Bruni, A. C., Passarino, G., Colao, R., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102068 · Cited by 88
Change in tropism upon immune escape by human immunodeficiency virus
McKnight, Á., Weiss, R. A., Shotton, C. F., Takeuchi, Y., Hoshino, H., & Clapham, P. R. (1995) · Journal of Virology · doi:10.1128/jvi.69.5.3167-3170.1995 · Cited by 85
Self-citationDynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo
Bagnarelli, P., Valenza, A., Menzo, S., Sampaolesi, R., Varaldo, P. E., Butini, L., Montroni, M., Perno, C. F., Aquaro, S., Mathez, D., et al. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.7603-7613.1996 · Cited by 84
Cadet, P., Rady, P. L., Tyring, S. K., Yandell, R. B., & Hughes, T. K. (1995) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(95)90164-7 · Cited by 83
Measles Virus-Mononuclear Cell Interactions
Borrow, P., & Oldstone, M. B. A. (1995) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-78621-1_6 · Cited by 82
Cell Cultures for Virology: Usability, Advantages, and Prospects
Dolskiy, A. A., Grishchenko, I. V., & Yudkin, D. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217978 · Cited by 84
“HIV causes acquired immunodeficiency syndrome (AIDS) [83].”
InfluentialEvaluation of Microalgae Antiviral Activity and Their Bioactive Compounds
Carbone, D. A., Pellone, P., Lubritto, C., & Ciniglia, C. (2021) · Antibiotics · doi:10.3390/antibiotics10060746 · Cited by 95
Interferons in the pathogenesis and treatment of human immunodeficiency virus infection
Poli, G., Biswas, P., & Fauci, A. S. (1994) · Antiviral Research · doi:10.1016/0166-3542(94)90069-8 · Cited by 78
Hu, W., Bowman, E. H., Delviks‐Frankenberry, K. A., & Pathak, V. K. (1997) · Journal of Virology · doi:10.1128/jvi.71.8.6028-6036.1997 · Cited by 87
Adkins, H. B., Blacklow, S. C., & Young, J. A. T. (2001) · Journal of Virology · doi:10.1128/jvi.75.8.3520-3526.2001 · Cited by 77
Impact of COVID‐19 and other viruses on reproductive health
Batiha, O., Al‐Deeb, T., Al‐zoubi, E., & Alsharu, E. (2020) · Andrologia · doi:10.1111/and.13791 · Cited by 80
“HIV infects cells in the human immune system mainly, T helper lymphocytes (specifically CD4+ T cells) leading to their depletion and with time acquired immunodeficiency syndrome (AIDS; Weiss, 1993).”
BackgroundXue, W., Jin, X., Ning, L., Wang, M., Liu, H., & Yao, X. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300541c · Cited by 77
New Insights into Chemistry and Anti-Infective Potential of Triazole Scaffold
Kharb, R., Yar, M. S., & Sharma, P. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711796391615 · Cited by 77
“Antiretroviral drugs are medications for the treatment of infection by retroviruses, primarily HIV which lead to AIDS [166-168].”
BackgroundDeceptive imprinting in the immune response against HIV-1
Köhler, H., Müller, S., & Nara, P. L. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90192-9 · Cited by 74
Baldinotti, F., Matteucci, D., Mazzetti, P., Giannelli, C., Bandecchi, P., Tozzini, F., & Bendinelli, M. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4572-4579.1994 · Cited by 74
Exonuclease III-based and gold nanoparticle-assisted DNA detection with dual signal amplification
Fan, Q. W., Zhao, J. T., Li, H., Zhu, L., & Li, G. (2012) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2012.01.003 · Cited by 73
Modelling the Course of an HIV Infection: Insights from Ecology and Evolution
Alizon, S., & Magnus, C. (2012) · Viruses · doi:10.3390/v4101984 · Cited by 91
“The question of how an HIV infection progresses from the acute phase to AIDS has been intensively discussed [20].”
BackgroundUse of Aptamers as Diagnostics Tools and Antiviral Agents for Human Viruses
González, V. M., Martín, M. E., Fernández, G., & García-Sacristán, A. (2016) · Pharmaceuticals · doi:10.3390/ph9040078 · Cited by 71
Mollison, D., Isham, V. S., & Grenfell, B. T. (1994) · Journal of the Royal Statistical Society Series A (Statistics in Society) · doi:10.2307/2983509 · Cited by 80
Neuveut, C., & Jeang, K. T. (1996) · Journal of Virology · doi:10.1128/jvi.70.8.5572-5581.1996 · Cited by 69
Retrovirus classification and cell interactions
Weiss, R. A. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/37.suppl_b.1 · Cited by 68
“Despite these new insights into viral dynamics we still do not know precisely how HIV causes AIDS (Weiss, 1993).”
BackgroundSelf-citationRole of host tRNAs and aminoacyl-tRNA synthetases in retroviral replication
Jin, D., & Musier-Forsyth, K. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.rev118.002957 · Cited by 67
“Retroviruses as a human health concern include HIV type 1 (HIV-1), the causative agent of acquired immune deficiency syndrome (AIDS) (1), and human T-cell leukemia virus type 1 (HTLV-1),(2) which causes adult T-cell leukemia/lymphoma and a demyelinating disease named HTLV-associated myelopathy/ tropical spastic parapa…”
BackgroundInfluence of microbial infections on the progression of HIV disease
Blanchard, A., Montagnier, L., & Gougeon, M. (1997) · Trends in Microbiology · doi:10.1016/s0966-842x(97)01089-5 · Cited by 67
Machine Learning Approaches to Bioinformatics
Yang, Z. R. (2010) · Science, engineering, and biology informatics · doi:10.1142/7454 · Cited by 79
Spira, A. I., & Ho, D. D. (1995) · Journal of Virology · doi:10.1128/jvi.69.1.422-429.1995 · Cited by 66
Rotten to the core: antivirals targeting the HIV-1 capsid core
McFadden, W. M., Snyder, A. A., Kirby, K. A., Tedbury, P. R., Raj, M., Wang, Z., & Sarafianos, S. G. (2021) · Retrovirology · doi:10.1186/s12977-021-00583-z · Cited by 73
Gallo, M., Defaus, S., & Andreu, D. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.11.010 · Cited by 69
The diverse roles and dynamic rearrangement of vimentin during viral infection
Zhang, Y., Wen, Z., Shi, X., Liu, Y., Eriksson, J., & Jiu, Y. (2020) · Journal of Cell Science · doi:10.1242/jcs.250597 · Cited by 66
“For instance, vimentin has been shown to interact with the third hypervariable region (V3 loop) of the viral protein gp120 of the human immunodeficiency virus (HIV) before the viral capsid fuses with the host membrane (Thomas et al., 1996; Weiss, 1993) (Table 2).”
BackgroundWoodham, A. W., Skeate, J. G., Sanna, A. M., Taylor, J. R., Silva, D. M. D., Cannon, P. M., & Kast, W. M. (2016) · AIDS Patient Care and STDs · doi:10.1089/apc.2016.0100 · Cited by 78
HIV-1 Tat protein enhances Microtubule polymerization
de Mareuil, J., Carre, M., Barbier, P., Campbell, G. R., Lancelot, S., Opi, S., Esquieu, D., Watkins, J. D., Prevot, C., Braguer, D., et al. (2005) · Retrovirology · doi:10.1186/1742-4690-2-5 · Cited by 62
HIV Receptors and the Pathogenesis of AIDS
Weiss, R. A. (1996) · Science · doi:10.1126/science.272.5270.1885 · Cited by 62
Self-citationMicroRNA regulation of p21 and TASK1 cellular restriction-factors enhances HIV-1 infection
Farberov, L., Herzig, E., Modai, S., Isakov, O., Hizi, A., & Shomron, N. (2015) · Journal of Cell Science · doi:10.1242/jcs.167817 · Cited by 62
Analysis of a model for the pathogenesis of AIDS
Stilianakis, N. I., Dietz, K., & Schenzle, D. (1997) · Mathematical Biosciences · doi:10.1016/s0025-5564(97)00018-7 · Cited by 60
Jiang, X., & Spencer, M. G. (2009) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2009.11.024 · Cited by 58
Prospects for a novel ultrashort pulsed laser technology for pathogen inactivation
Tsen, S.-W. D., Wu, T. C., Kiang, J. G., & Tsen, K. T. (2012) · Journal of Biomedical Science · doi:10.1186/1423-0127-19-62 · Cited by 58
Gilbert, P. B., Self, S. G., & Ashby, M. A. (1998) · Biometrics · doi:10.2307/2533835 · Cited by 58
“Examples of important phenotypes are serotype, cellular or tissue tropisms (which may reflect route of transmission and are the strongest known determinants of transmission (Weiss, 1993)), and surrogates for severity of HIV disease, such as capacity of virus to replicate or to induce synctia.”
BackgroundLü, P., Wei, X., & Zhang, R. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.04.030 · Cited by 58
Bernier, R., Barbeau, B., Tremblay, M. J., & Olivier, M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.6.2881 · Cited by 67
Shaat, M., & Abdelkefi, A. (2015) · Microsystem Technologies · doi:10.1007/s00542-015-2421-y · Cited by 56
The Surprising Role of Amyloid Fibrils in HIV Infection
Castellano, L. M., & Shorter, J. (2012) · Biology · doi:10.3390/biology1010058 · Cited by 64
Koszelska, K., Popławski, T., Ciesielski, W., & Smarzewska, S. (2018) · Bioelectrochemistry · doi:10.1016/j.bioelechem.2018.06.002 · Cited by 56
The keys of oxidative stress in acquired immune deficiency syndrome apoptosis
Alvira, D. R., & Roche, E. (1998) · Medical Hypotheses · doi:10.1016/s0306-9877(98)90113-x · Cited by 56
Liegler, T. J., Yonemoto, W. M., Elbeik, T., Vittinghoff, E., Buchbinder, S., & Greene, W. C. (1998) · The Journal of Infectious Diseases · doi:10.1086/515378 · Cited by 56
Anatomy of Viral Persistence: Mechanisms of Persistence and Associated Disease
de la Torre, J. C., & Oldstone, M. B. A. (1996) · Advances in virus research · doi:10.1016/s0065-3527(08)60075-5 · Cited by 56
ADARs and the Balance Game between Virus Infection and Innate Immune Cell Response
Tomaselli, S., Galeano, F., Locatelli, F., & Gallo, A. (2015) · Current Issues in Molecular Biology · doi:10.21775/cimb.017.037 · Cited by 55
“Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS).”
BackgroundInfluentialMüller, V., Marée, A. F. M., & de Boer, R. J. (2001) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2000.1358 · Cited by 55
Association of Mycoplasma penetrans with Human Immunodeficiency Virus Infection
Grau, O., Slizewicz, B., Tuppin, P., Launay, V., Bourgeois, E., Sagot, N., Moynier, M., Lafeuillade, A., Bachelez, H., Clauvel, J., et al. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/172.3.672 · Cited by 55
Huang, Y., Zhang, L., & Ho, D. D. (1995) · Journal of Virology · doi:10.1128/jvi.69.12.8142-8146.1995 · Cited by 55
Weiss, R. A. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03645.x · Cited by 54
Self-citationShiang, Y., Ou, C., Chen, S.-J., Ou, T.-Y., Lin, H. ‐., Huang, C., & Chang, H. (2013) · Nanoscale · doi:10.1039/c3nr33403a · Cited by 53
Has Molecular Docking Ever Brought us a Medicine?
Phillips, M. A., Stewart, M. A., Woodling, D. L., & Xie, Z. (2018) · InTech eBooks · doi:10.5772/intechopen.72898 · Cited by 57
“Acquired immunodeficiency syndrome (AIDS) is acquired in humans by the retrovirus HIV [13].”
Background
Metadata
- Authors
- Weiss, R. A.
- Affiliations
- Institute of Cancer Research (GB)
- Corresponding author
- Weiss, Robin A.
- ORCID
- Weiss, Robin A.
- Venue
- Science
- Published
- 1993-05-28
- Volume
- 260
- Issue
- 5112
- Pages
- 1273-1279
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2096110335
- Cited by
- 680
- References
- 130
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 15 · 2023: 16 · 2022: 36 · 2021: 26 · 2020: 28 · 2019: 21 · 2018: 24 · 2017: 19 · 2016: 28 · 2015: 40 · 2014: 42 · 2013: 33 · 2012: 37
- FWCI
- 4.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Keywords
- HIV pathogenesis, AIDS, HIV tropism, apoptosis, macrophages, dendritic cells, viral latency, autoimmune disease, immunodeficiency
- MeSH terms
- Acquired Immunodeficiency Syndrome, Animals, Antigenic Variation, Autoimmune Diseases, Dendritic Cells, HIV, Humans, Macrophages, T-Lymphocytes, Genetic Variation, Virulence, HIV Antigens, HIV Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.